1. accedaCRIS
  2. Publicaciones
  3. Artículos
Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/43486
DC FieldValueLanguage
dc.contributor.authorRubio Sánchez, Saraen_US
dc.contributor.authorQuintana Aguiar, José Martínen_US
dc.contributor.authorLópez, Marianaen_US
dc.contributor.authorEiroa, José Luisen_US
dc.contributor.authorTriana, Jorgeen_US
dc.contributor.authorEstévez Rosas, Francisco Jesúsen_US
dc.contributor.otherEstevez, Francisco-
dc.contributor.otherRubio, Sara-
dc.contributor.otherQuintana, Jose-
dc.contributor.otherRubio Sánchez, Sara-
dc.date.accessioned2018-11-21T15:32:45Z-
dc.date.available2018-11-21T15:32:45Z-
dc.date.issued2006en_US
dc.identifier.issn0014-2999en_US
dc.identifier.urihttp://hdl.handle.net/10553/43486-
dc.description.abstractWe have analyzed the cytotoxicity of 22 compounds with a phenylbenzo-gamma-pirone core structure, most of them obtained from natural sources, in five human tumor cell lines (HL-60, A431, SK-OV-3, HeLa and HOS). Betuletol 3-methyl ether and its diacetate were the most cytotoxic compounds. The HL-60 cell line was especially sensitive to these compounds, with IC50 values of approximately 1 microM. Treatment of HL-60 cells with betuletol 3-methyl ether was associated with apoptosis induction which was prevented by a non-specific caspase inhibitor (z-VAD-fmk) and also by a specific inhibitor of caspase-8 (z-IETD-fmk) indicating activation of the extrinsic apoptotic pathway. The results suggest that betuletol 3-methyl ether has potential as new anticancer agent.en_US
dc.languageengen_US
dc.publisher0014-2999-
dc.relationNuevos Compuestos Antileucémicosen_US
dc.relation.ispartofEuropean journal of pharmacologyen_US
dc.sourceEuropean Journal of Pharmacology [ISSN 0014-2999], v. 548, p. 9-20en_US
dc.subject32 Ciencias médicasen_US
dc.subject.otherApoptosisen_US
dc.subject.otherFlavonoidsen_US
dc.subject.otherCytotoxic activityen_US
dc.subject.otherCaspasesen_US
dc.subject.otherDNA fragmentationen_US
dc.subject.otherPoly(ADP-ribose) polymeraseen_US
dc.titlePhenylbenzopyrones structure-activity studies identify betuletol derivatives as potential antitumoral agentsen_US
dc.typeinfo:eu-repo/semantics/Articleen_US
dc.typeArticleen_US
dc.identifier.doi10.1016/j.ejphar.2006.07.020en_US
dc.identifier.scopus33748704067-
dc.identifier.isi000241172600002-
dcterms.isPartOfEuropean Journal Of Pharmacology-
dcterms.sourceEuropean Journal Of Pharmacology[ISSN 0014-2999],v. 548 (1-3), p. 9-20-
dc.contributor.authorscopusid22635323400-
dc.contributor.authorscopusid8681043500-
dc.contributor.authorscopusid22985994700-
dc.contributor.authorscopusid6507583429-
dc.contributor.authorscopusid6602859915-
dc.contributor.authorscopusid7003810011-
dc.description.lastpage20en_US
dc.description.firstpage9en_US
dc.relation.volume548en_US
dc.investigacionCiencias de la Saluden_US
dc.type2Artículoen_US
dc.identifier.wosWOS:000241172600002-
dc.contributor.daisngid4276242-
dc.contributor.daisngid128315-
dc.contributor.daisngid5158464-
dc.contributor.daisngid2831014-
dc.contributor.daisngid1400733-
dc.contributor.daisngid384944-
dc.identifier.investigatorRIDK-5125-2014-
dc.identifier.investigatorRIDK-4656-2013-
dc.identifier.investigatorRIDK-5709-2014-
dc.identifier.investigatorRIDNo ID-
dc.contributor.wosstandardWOS:Rubio, S-
dc.contributor.wosstandardWOS:Quintana, J-
dc.contributor.wosstandardWOS:Lopez, M-
dc.contributor.wosstandardWOS:Eiroa, JL-
dc.contributor.wosstandardWOS:Triana, J-
dc.contributor.wosstandardWOS:Estevez, F-
dc.date.coverdateOctubre 2006en_US
dc.identifier.ulpgcSíes
dc.description.jcr2,522
dc.description.jcrqQ2
dc.description.scieSCIE
item.grantfulltextnone-
item.fulltextSin texto completo-
crisitem.author.deptGIR IUIBS: Bioquímica-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Bioquímica y Biología Molecular, Fisiología, Genética e Inmunología-
crisitem.author.deptGIR IUIBS: Bioquímica-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Bioquímica y Biología Molecular, Fisiología, Genética e Inmunología-
crisitem.author.deptGIR IUIBS: Bioquímica-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptGIR IUIBS: Bioquímica-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Bioquímica y Biología Molecular, Fisiología, Genética e Inmunología-
crisitem.author.orcid0000-0001-7633-1285-
crisitem.author.orcid0000-0001-8225-4538-
crisitem.author.orcid0000-0002-4986-8332-
crisitem.author.orcid0000-0002-9728-2774-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.fullNameRubio Sánchez, Sara-
crisitem.author.fullNameQuintana Aguiar, José Martín-
crisitem.author.fullNameEiroa Martínez,José Luis-
crisitem.author.fullNameEstévez Rosas, Francisco Jesús-
crisitem.project.principalinvestigatorEstévez Rosas, Francisco Jesús-
Appears in Collections:Artículos
Show simple item record

SCOPUSTM   
Citations

42
checked on Mar 30, 2025

WEB OF SCIENCETM
Citations

43
checked on Mar 30, 2025

Page view(s)

80
checked on May 4, 2024

Google ScholarTM

Check

Altmetric


Share


Export metadata


Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.